Prevention and treatment of cancer-related infections, version 2.2016

Lindsey Robert Baden, Sankar Swaminathan, Michael Angarone, Gayle Blouin, Bernard C. Camins, Corey Casper, Brenda Cooper, Erik R. Dubberke, Ashley Morris Engemann, Alison Gail Freifeld, John N. Greene, James I. Ito, Daniel R. Kaul, Mark E. Lustberg, Jose G. Montoya, Ken Rolston, Gowri Satyanarayana, Brahm Segal, Susan K. Seo, Shmuel ShohamRandy Taplitz, Jeffrey Topal, John W. Wilson, Karin G. Hoffmann, Courtney Smith

Research output: Contribution to journalReview article

93 Citations (Scopus)

Abstract

Infectious diseases are important causes of morbidity and mortality in patients with cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections characterize the major pathogens to which patients with cancer are susceptible, with a focus on the prevention, diagnosis, and treatment of major common and opportunistic infections. This portion of the guidelines highlights the sections on antifungal and antiviral prophylaxis. Antifungal and antiviral prophylaxis recommendations have expanded over the past few years. New agents for the treatment of fungal infections and incorporation of therapeutic drug monitoring are presented. Antiviral prophylaxis for hepatitis B and management considerations for hepatitis C and HIV have been further developed.

Original languageEnglish (US)
Pages (from-to)882-913
Number of pages32
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Second Primary Neoplasms
Antiviral Agents
Infection
Guidelines
Mycoses
Drug Monitoring
Opportunistic Infections
Hepatitis C
Hepatitis B
Practice Guidelines
Communicable Diseases
Neoplasms
HIV
Morbidity
Mortality
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Baden, L. R., Swaminathan, S., Angarone, M., Blouin, G., Camins, B. C., Casper, C., ... Smith, C. (2016). Prevention and treatment of cancer-related infections, version 2.2016. JNCCN Journal of the National Comprehensive Cancer Network, 14(7), 882-913. https://doi.org/10.6004/jnccn.2016.0093

Prevention and treatment of cancer-related infections, version 2.2016. / Baden, Lindsey Robert; Swaminathan, Sankar; Angarone, Michael; Blouin, Gayle; Camins, Bernard C.; Casper, Corey; Cooper, Brenda; Dubberke, Erik R.; Engemann, Ashley Morris; Freifeld, Alison Gail; Greene, John N.; Ito, James I.; Kaul, Daniel R.; Lustberg, Mark E.; Montoya, Jose G.; Rolston, Ken; Satyanarayana, Gowri; Segal, Brahm; Seo, Susan K.; Shoham, Shmuel; Taplitz, Randy; Topal, Jeffrey; Wilson, John W.; Hoffmann, Karin G.; Smith, Courtney.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, No. 7, 01.07.2016, p. 882-913.

Research output: Contribution to journalReview article

Baden, LR, Swaminathan, S, Angarone, M, Blouin, G, Camins, BC, Casper, C, Cooper, B, Dubberke, ER, Engemann, AM, Freifeld, AG, Greene, JN, Ito, JI, Kaul, DR, Lustberg, ME, Montoya, JG, Rolston, K, Satyanarayana, G, Segal, B, Seo, SK, Shoham, S, Taplitz, R, Topal, J, Wilson, JW, Hoffmann, KG & Smith, C 2016, 'Prevention and treatment of cancer-related infections, version 2.2016', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 7, pp. 882-913. https://doi.org/10.6004/jnccn.2016.0093
Baden, Lindsey Robert ; Swaminathan, Sankar ; Angarone, Michael ; Blouin, Gayle ; Camins, Bernard C. ; Casper, Corey ; Cooper, Brenda ; Dubberke, Erik R. ; Engemann, Ashley Morris ; Freifeld, Alison Gail ; Greene, John N. ; Ito, James I. ; Kaul, Daniel R. ; Lustberg, Mark E. ; Montoya, Jose G. ; Rolston, Ken ; Satyanarayana, Gowri ; Segal, Brahm ; Seo, Susan K. ; Shoham, Shmuel ; Taplitz, Randy ; Topal, Jeffrey ; Wilson, John W. ; Hoffmann, Karin G. ; Smith, Courtney. / Prevention and treatment of cancer-related infections, version 2.2016. In: JNCCN Journal of the National Comprehensive Cancer Network. 2016 ; Vol. 14, No. 7. pp. 882-913.
@article{418371586b7f4af99a6b991995ceb2bc,
title = "Prevention and treatment of cancer-related infections, version 2.2016",
abstract = "Infectious diseases are important causes of morbidity and mortality in patients with cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections characterize the major pathogens to which patients with cancer are susceptible, with a focus on the prevention, diagnosis, and treatment of major common and opportunistic infections. This portion of the guidelines highlights the sections on antifungal and antiviral prophylaxis. Antifungal and antiviral prophylaxis recommendations have expanded over the past few years. New agents for the treatment of fungal infections and incorporation of therapeutic drug monitoring are presented. Antiviral prophylaxis for hepatitis B and management considerations for hepatitis C and HIV have been further developed.",
author = "Baden, {Lindsey Robert} and Sankar Swaminathan and Michael Angarone and Gayle Blouin and Camins, {Bernard C.} and Corey Casper and Brenda Cooper and Dubberke, {Erik R.} and Engemann, {Ashley Morris} and Freifeld, {Alison Gail} and Greene, {John N.} and Ito, {James I.} and Kaul, {Daniel R.} and Lustberg, {Mark E.} and Montoya, {Jose G.} and Ken Rolston and Gowri Satyanarayana and Brahm Segal and Seo, {Susan K.} and Shmuel Shoham and Randy Taplitz and Jeffrey Topal and Wilson, {John W.} and Hoffmann, {Karin G.} and Courtney Smith",
year = "2016",
month = "7",
day = "1",
doi = "10.6004/jnccn.2016.0093",
language = "English (US)",
volume = "14",
pages = "882--913",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Prevention and treatment of cancer-related infections, version 2.2016

AU - Baden, Lindsey Robert

AU - Swaminathan, Sankar

AU - Angarone, Michael

AU - Blouin, Gayle

AU - Camins, Bernard C.

AU - Casper, Corey

AU - Cooper, Brenda

AU - Dubberke, Erik R.

AU - Engemann, Ashley Morris

AU - Freifeld, Alison Gail

AU - Greene, John N.

AU - Ito, James I.

AU - Kaul, Daniel R.

AU - Lustberg, Mark E.

AU - Montoya, Jose G.

AU - Rolston, Ken

AU - Satyanarayana, Gowri

AU - Segal, Brahm

AU - Seo, Susan K.

AU - Shoham, Shmuel

AU - Taplitz, Randy

AU - Topal, Jeffrey

AU - Wilson, John W.

AU - Hoffmann, Karin G.

AU - Smith, Courtney

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Infectious diseases are important causes of morbidity and mortality in patients with cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections characterize the major pathogens to which patients with cancer are susceptible, with a focus on the prevention, diagnosis, and treatment of major common and opportunistic infections. This portion of the guidelines highlights the sections on antifungal and antiviral prophylaxis. Antifungal and antiviral prophylaxis recommendations have expanded over the past few years. New agents for the treatment of fungal infections and incorporation of therapeutic drug monitoring are presented. Antiviral prophylaxis for hepatitis B and management considerations for hepatitis C and HIV have been further developed.

AB - Infectious diseases are important causes of morbidity and mortality in patients with cancer. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections characterize the major pathogens to which patients with cancer are susceptible, with a focus on the prevention, diagnosis, and treatment of major common and opportunistic infections. This portion of the guidelines highlights the sections on antifungal and antiviral prophylaxis. Antifungal and antiviral prophylaxis recommendations have expanded over the past few years. New agents for the treatment of fungal infections and incorporation of therapeutic drug monitoring are presented. Antiviral prophylaxis for hepatitis B and management considerations for hepatitis C and HIV have been further developed.

UR - http://www.scopus.com/inward/record.url?scp=84978910660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978910660&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2016.0093

DO - 10.6004/jnccn.2016.0093

M3 - Review article

C2 - 27407129

AN - SCOPUS:84978910660

VL - 14

SP - 882

EP - 913

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -